HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatocyte nuclear factor-1β shapes the energetic homeostasis of kidney tubule cells.

Abstract
Energetic metabolism controls key steps of kidney development, homeostasis, and epithelial repair following acute kidney injury (AKI). Hepatocyte nuclear factor-1β (HNF-1β) is a master transcription factor that controls mitochondrial function in proximal tubule (PT) cells. Patients with HNF1B pathogenic variant display a wide range of kidney developmental abnormalities and progressive kidney fibrosis. Characterizing the metabolic changes in PT cells with HNF-1β deficiency may help to identify new targetable molecular hubs involved in HNF1B-related kidney phenotypes and AKI. Here, we combined 1 H-NMR-based metabolomic analysis in a murine PT cell line with CrispR/Cas9-induced Hnf1b invalidation (Hnf1b-/- ), clustering analysis, targeted metabolic assays, and datamining of published RNA-seq and ChIP-seq dataset to identify the role of HNF-1β in metabolism. Hnf1b-/- cells grown in normoxic conditions display intracellular ATP depletion, increased cytosolic lactate concentration, increased lipid droplet content, failure to use pyruvate for energetic purposes, increased levels of tricarboxylic acid (TCA) cycle intermediates and oxidized glutathione, and a reduction of TCA cycle byproducts, all features consistent with mitochondrial dysfunction and an irreversible switch toward glycolysis. Unsupervised clustering analysis showed that Hnf1b-/- cells mimic a hypoxic signature and that they cannot furthermore increase glycolysis-dependent energetic supply during hypoxic challenge. Metabolome analysis also showed alteration of phospholipid biosynthesis in Hnf1b-/- cells leading to the identification of Chka, the gene coding for choline kinase α, as a new putative target of HNF-1β. HNF-1β shapes the energetic metabolism of PT cells and HNF1B deficiency in patients could lead to a hypoxia-like metabolic state precluding further adaptation to ATP depletion following AKI.
AuthorsAlexis Piedrafita, Stéphane Balayssac, Audrey Casemayou, Jean-Sébastien Saulnier-Blache, Alexandre Lucas, Jason S Iacovoni, Benjamin Breuil, Dominique Chauveau, Stéphane Decramer, Myriam Malet-Martino, Joost P Schanstra, Stanislas Faguer
JournalFASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 35 Issue 11 Pg. e21931 (11 2021) ISSN: 1530-6860 [Electronic] United States
PMID34653285 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 Federation of American Societies for Experimental Biology.
Chemical References
  • Hnf1b protein, mouse
  • Hepatocyte Nuclear Factor 1-beta
Topics
  • Acute Kidney Injury (metabolism)
  • Animals
  • CRISPR-Cas Systems
  • Cell Hypoxia (genetics)
  • Cell Line
  • Cell Proliferation (genetics)
  • Cell Survival (genetics)
  • Epithelial Cells (metabolism)
  • Gene Deletion
  • Gene Expression Regulation
  • Gene Knockout Techniques (methods)
  • Glycolysis (genetics)
  • Hepatocyte Nuclear Factor 1-beta (genetics, metabolism)
  • Homeostasis (genetics)
  • Humans
  • Kidney Tubules, Proximal (cytology)
  • Metabolome
  • Mice
  • Signal Transduction (genetics)
  • Transcriptome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: